Pilot Studies of the Effect of Aging on Mucociliary Clearance
Pilot Studies of the Effect of Aging on Mucociliary Clearance
批准号:
8358977
负责人:
LAWRENCE E OSTROWSKI
金额:
$7.6万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2014-06-30
关键词:
Agar Gel ElectrophoresisAgeAge ReportingAgingBiological ModelsC57BL/6 MouseCause of DeathCellsChronicCiliaCommunicable DiseasesCommunitiesCystic FibrosisDefectDefense MechanismsDevelopmentDiseaseElderlyElectron MicroscopyExhibitsFrequenciesGamma CamerasGoalsHealthHistologyHost DefenseHumanHydration statusImmunocompetentIncidenceIndividualInfectionIon TransportLabelLifeLungLung diseasesMeasuresMonitorMorbidity - disease rateMovementMucinsMucociliary ClearanceMucous body substanceMusMutationNasal cavityNasopharynxNosePatientsPilot ProjectsPneumoniaPopulationPredispositionPreventionPrimary Ciliary DyskinesiasPropertyProteinsRegulationReportingResearchRespiratory Tract InfectionsRespiratory physiologySalineSamplingSeveritiesStudy modelsSystemTeflonTestingTherapeuticTissue SampleTracheaTreatment EffectivenessVideo MicroscopyWestern Blottingage effectage relatedagedairway surface liquiddesigneffective therapyimprovedmortalitymouse modelnovel strategiesnovel therapeuticsolder patientparticlepreventrespiratory
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Respiratory tract infections are a major cause of morbidity and mortality in the elderly population. In this population, pneumonia is the leading cause of death due to infectious disease, and the incidence of community-acquired pneumonia increases with every decade of life. One of the most important innate defense mechanisms against respiratory infections is the mucociliary clearance (MCC) system. Individuals with genetic defects in MCC suffer from chronic pulmonary infections, demonstrating the importance of MCC to host defense. Importantly, there is good evidence to suggest that MCC declines with age. Therefore it is likely that a reduced rate of MCC in the elderly, increases their susceptibiliy to respiratory infections. However, none of the studies reported to date has identified the mechanism(s) responsible for the reduced rate of MCC in older subjects, nor have they explored the effectiveness of treatments to improve MCC. Surprisingly, there have been no studies of the effect of aging on MCC in a mouse model. The lack of an established mouse model is a significant barrier, both to studies of the mechanisms responsible for the reduced rate of MCC in the elderly and to the development and testing of therapeutics designed to improve MCC in this population. Therefore the goals of this proposal are to 1) accurately assess the effect of aging on MCC in an established mouse model of aging, and 2) to examine the effect of aging on the key components of MCC to begin to identify the mechanisms responsible for the decreased rate of MCC in older subjects. Specific aim 1. To test the hypothesis that MCC is reduced in aged mice. Mucociliary clearance will be measured in the trachea and nasopharynx of 3, 6, 12, and 24 month old C57BL/6 mice by tracking the movement of endogenous mucus particles or instilled fluorescent beads. Specific aim 2. To examine the effect of age on individual components of the MCC. 2a) To test the hypothesis that aged mice exhibit defects in the ciliary component of MCC. Ciliary beat frequency (CBF) will be measured by video microscopy in the trachea and nasal cavity of 3, 6, 12, and 24 month old mice. The number of ciliated cells will be determined by histology, and the incidence of axonemal structural defects will be quantified by electron microscopy. 2b) To test the hypothesis that aged mice exhibit defects in the mucus component of MCC. The number of mucous cells in the nasal cavity and trachea will be determined by histology in samples from mice of different ages. The amount of secreted and total airway mucin in the lung will be quantified by agarose gel electrophoresis and Western blotting. 2c) To test the hypothesis that aged mice exhibit defects in the regulation of ion transport. The ion transport properties of the upper and lower airways wil be determined, as these are reflective of the hydration status of the ASL. Tissue samples from mice 3, 6, 12, and 24 months old will be studied in Ussing chambers.
PUBLIC HEALTH RELEVANCE: The long-term goal of this research is to understand the cause of reduced mucociliary clearance and the high incidence of respiratory infections (pneumonia) in the elderly population, and to develop effective treatments to improve mucociliary clearance and prevent respiratory disease. In these pilot studies, mucociliary clearance will be measured in young and old mice to determine if mice can be used as a model for studies of mucociliary clearance in humans. Additional studies will investigate some of the possible mechanisms that may contribute to the reduced mucociliary clearance and increased respiratory infections in the elderly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia
-
批准号:8721483
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2013
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia
-
批准号:8480072
-
项目类别:
-
资助金额:$36.18万
-
财政年份:2013
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia
-
批准号:8829895
-
项目类别:
-
资助金额:$37.43万
-
财政年份:2013
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
-
批准号:10363650
-
项目类别:
-
资助金额:$63.39万
-
财政年份:2013
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
-
批准号:10570977
-
项目类别:
-
资助金额:$63.39万
-
财政年份:2013
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
-
批准号:9887916
-
项目类别:
-
资助金额:$67.31万
-
财政年份:2013
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia
-
批准号:9242066
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2013
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Pilot Studies of the Effect of Aging on Mucociliary Clearance
-
批准号:8513866
-
项目类别:
-
资助金额:$7.18万
-
财政年份:2012
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Pilot Studies of Gene Therapy for Primary Ciliary Dyskinesia
-
批准号:7935357
-
项目类别:
-
资助金额:$48.24万
-
财政年份:2009
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Pilot Studies of Gene Therapy for Primary Ciliary Dyskinesia
-
批准号:7829389
-
项目类别:
-
资助金额:$48.38万
-
财政年份:2009
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Conditional Deletion of Dnaic1 as a Model of Primary Ciliary Dyskinesia
-
批准号:7230116
-
项目类别:
-
资助金额:$21.26万
-
财政年份:2006
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
Conditional Deletion of Dnaic1 as a Model of Primary Ciliary Dyskinesia
-
批准号:7080918
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2006
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
A Ciliated Cell-Specific Promoter for Gene Therapy of CF
-
批准号:6868067
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2002
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
A Ciliated Cell-Specific Promoter for Gene Therapy of CF
-
批准号:6623454
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2002
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
A Ciliated Cell-Specific Promoter for Gene Therapy of CF
-
批准号:6741423
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2002
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
A Ciliated Cell-Specific Promoter for Gene Therapy of CF
-
批准号:6465946
-
项目类别:
-
资助金额:$29.1万
-
财政年份:2002
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
IDENTIFICATION OF BIOCHEMICAL ABNORMALITIES IN PCD CILIA
-
批准号:2884950
-
项目类别:
-
资助金额:$19.3万
-
财政年份:1999
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
IDENTIFICATION OF BIOCHEMICAL ABNORMALITIES IN PCD CILIA
-
批准号:6184714
-
项目类别:
-
资助金额:$17.56万
-
财政年份:1999
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
IDENTIFICATION OF BIOCHEMICAL ABNORMALITIES IN PCD CILIA
-
批准号:6390440
-
项目类别:
-
资助金额:$18.09万
-
财政年份:1999
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
IDENTIFICATION OF BIOCHEMICAL ABNORMALITIES IN PCD CILIA
-
批准号:6537633
-
项目类别:
-
资助金额:$18.63万
-
财政年份:1999
-
负责人:LAWRENCE E OSTROWSKI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: